The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...

Though an antiretroviral medication called PrEP provides near-perfect protection against HIV, patients must often surmount ...

A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.

She's in bed waiting, and you can't track down where on your body that smell is coming from. Make sure you're clean for her in 5 flat.

Truvada clears from the bloodstream within 2 to 5 days, but may remain present in cells for 7 to 10 days. Taking it once a day is important for it to be effective. Truvada is a prescription medication ...

With World Acquired Immunodeficiency Syndrome Day approaching Dec. 1, it’s important to learn about some of the prevention methods and efforts. Besides correctly and consistently using safer sex ...

Gilead Sciences (NASDAQ:GILD) announced on Tuesday that the European Commission granted marketing authorization for its antiviral therapy lenacapavir as a twice-yearly option for the prevention of HIV ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The suit continues a long ...

A twice yearly injection that is highly effective in preventing HIV transmission could dramatically reduce infections and save lives — if the people who would most benefit from the drug can obtain it, ...

Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...